home / stock / mdma:cc / mdma:cc news

MDMA:CC News and Press, Pharmala Biotech Holdings Inc. From 03/10/25

Stock Information
Company Name: Pharmala Biotech Holdings Inc.
Stock Symbol: MDMA:CC
Market: CNQC
Website: pharmala.ca
Menu
MDMA:CC MDMA:CC Quote MDMA:CC Short MDMA:CC News MDMA:CC Articles MDMA:CC Message Board
Get MDMA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MDMA:CC - PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La...
MDMA:CC - PharmAla Completes Shipment of LaNeo(TM) MDMA to UCLA for Schizophrenia Study

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its La...

MDMA:CC - PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo(TM) MDMA

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of M...

MDMA:CC - PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli

TORONTO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...
MDMA:CC - PharmAla Issues Q1 Financial Statements

TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...

MDMA:CC - PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel

TORONTO, Jan. 20, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of M...

Previous 10 Next 10